Author

Yujun Dong

Observed names: Y Dong, Y J Dong, Y. Dong, Y.-J. Dong, Yi Dong, Yu-Jun Dong, Yu-jun Dong, YuJun Dong, Yu‐Jun Dong, Yu‐jun Dong

Institution: Peking University First Hospital

Observed institutions: Hebei Medical University, Hubei University of Medicine, National Institutes of Health, Sun Yat-sen University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Walter Reed National Military Medical Center, Peking Union Medical College Hospital, Third Hospital of Hebei Medical University, The First Affiliated Hospital, Sun Yat-sen University, Peking University First Hospital, National Cancer Institute, Center for Cancer Research, Jiangsu Province Hospital, Tongji Hospital, Xiang Yang No.1 People's Hospital, Huazhong University of Science and Technology

ORCID: 0000-0002-7935-6194

Observed ORCID: 0000-0002-7935-6194

OpenAlex ID: A5103124992

Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor

2015 · Yujun Dong, Mingyue Wang, et al. · British Journal of Haematology · 87

PDF

Renal involvement in a large cohort of Chinese patients with Castleman disease

2011 · Damin Xu, Jicheng Lv, et al. · Nephrology Dialysis Transplantation · 69

Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease

2018 · Yujun Dong, Lu Zhang, et al. · Annals of Hematology · 34

CT103A, a novel fully human BCMA-targeting CAR-T cells, in patients with relapsed/refractory multiple myeloma: Updated results of phase 1b/2 study (FUMANBA-1).

2023 · Chunrui Li, Di Wang, et al. · Journal of Clinical Oncology · 28

Combined prophylactic and therapeutic cancer vaccine: Enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA‐A2 mice

2006 · Jiahua Qian, Yujun Dong, et al. · International Journal of Cancer · 28

A prospective, multicenter study of bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory iMCD

2022 · Lu Zhang, Miao-yan Zhang, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 25

Identification of H-2Db-Specific CD8+ T-Cell Epitopes From Mouse VEGFR2 That Can Inhibit Angiogenesis and Tumor Growth

2005 · Yujun Dong, Jiahua Qian, et al. · Journal of Immunotherapy · 25

Clinical and laboratory characterization of a large cohort of patients with Castleman disease retrospectively collected from a single center

2009 · Yujun Dong, Jia Na, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 23

Mesenchymal stem cells alleviate idiopathic pneumonia syndrome by modulating T cell function through CCR2-CCL2 axis

2021 · Min Cao, Huihui Liu, et al. · Stem Cell Research & Therapy · 21

PDF

Updated Results of Fumanba-1: A Phase 1b/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

2022 · Chunrui Li, Di Wang, et al. · Blood · 18

CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model

2017 · Shengchao Miao, Bo Tang, et al. · Molecular Immunology · 18

Real‐world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis

2023 · Ping Yang, Qing‐qing Cai, et al. · Cancer Medicine · 17

PDF

[Recommendations of diagnosis and treatment of primary Sjögren's syndrome in China].

2020 · W Zhang, X M Li, et al. · PubMed · 17

Predominant Stroma-Rich Feature in Hyaline Vascular Variant of Castleman Disease Is Associated With Paraneoplastic Pemphigus

2020 · Leyi Wang, Lin Nong, et al. · American Journal of Clinical Pathology · 17

Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus

2006 · Xuan Zhang, Huijun Shu, et al. · Annals of the Rheumatic Diseases · 17

PDF

Artificial intelligence for diagnosis and prognosis prediction of natural killer/T cell lymphoma using magnetic resonance imaging

2024 · YuChen Zhang, YiShu Deng, et al. · Cell Reports Medicine · 16

A Phase 1/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

2021 · Chunrui Li, Di Wang, et al. · Blood · 15

CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function

2016 · Bo Tang, Hanyun Ren, et al. · Inflammation Research · 15

Features and Risk Factors for Paraneoplastic Autoimmune Multiorgan Syndrome in 145 Chinese Patients

2020 · M Wang, F Li, et al. · Acta Dermato Venereologica · 14

Efficacy and safety of coadministration of venetoclax and anti-fungal agents under therapeutic drug monitor in unfit acute myeloid leukemia and high-risk myelodysplastic syndrome with neutropenia: a single-center retrospective study

2023 · Lihong Wang, Liang Gao, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 13

Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy

2023 · Bingjie Wang, Qian Wang, et al. · Annals of Hematology · 13

PDF

684P Phase I trial of SHR-A1811 in HER2-expressing advanced gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJ) and colorectal cancer (CRC)

2023 · J. Li, S. Luo, et al. · Annals of Oncology · 12

PDF

TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia

2016 · Ming Chu, Kailin Yin, et al. · Oncotarget · 11

PDF

The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma

2023 · Peiyu Yang, Fan Zhou, et al. · HemaSphere · 10

LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease via Skewing Allogeneic T Cells Polarization Towards Treg Cells

2021 · Huihui Liu, Zhengyu Yu, et al. · Frontiers in Immunology · 10

PDF

Works count: 155

Citation count: 829

H-index: 16

I10-index: 26